70 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
to achieve high levels of subject retention and protocol compliance in endemic regions. The vaccine is approved in multiple endemic and non-endemic countries
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
Standards for the Professional Practice of Internal Auditing (IIA Standards)” issued by the Institute of Internal Auditors. (ii) System for retention
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
-generation dengue vaccine, and it considered the
- 15 -
Translation for reference purpose only
need to achieve high levels of subject retention
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
, and it considered the need to achieve high levels of subject retention and protocol compliance in endemic regions. The vaccine is approved in multiple endemic
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
of Internal Auditing (IIA Standards)” issued by the Institute of Internal Auditors. (ii) System for retention and management of information concerning
6-K
EX-99.1
5rvwt86zd45h4irqi
23 Jun 23
Current report (foreign)
6:13am
6-K
1o1flciqt
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
axo8bgggi 7p4mf
30 May 23
Current report (foreign)
6:11am
6-K
ldg19tm4u8ogg g1t
11 Jul 22
Current report (foreign)
6:05am
6-K
a8ghz
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
mqpa6ux8x0o
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
ad0y7erw9qbg996ilre
31 May 22
Current report (foreign)
12:00am
6-K
zzgw5k
1 Nov 21
Current report (foreign)
6:04am
6-K
fh2777ce9ij6otb
6 Aug 21
Current report (foreign)
6:10am
6-K
g6wey6cxvy0gz
19 Jul 21
Current report (foreign)
6:02am